Latest Articles
Endometriosis, the disease that can take a decade to diagnose - Luxembourg Times
Endometriosis, the disease that can take a decade to diagnose Luxembourg Times
Published: March 11, 2025, 5 p.m.
'Finally paying heed to female risk factors': Gynaecological disorders linked to 28% higher risk of heart and brain disease - Australian Doctor
'Finally paying heed to female risk factors': Gynaecological disorders linked to 28% higher risk of heart and brain disease Australian Doctor
Published: March 11, 2025, 5:07 a.m.
Cumbrian brewery to release new beer for International Women's Day - MSN
Cumbrian brewery to release new beer for International Women's Day MSN
Published: March 9, 2025, 7:50 a.m.
Womb cancer's earliest symptoms and how the disease is treated - MSN
Womb cancer's earliest symptoms and how the disease is treated MSN
Published: March 9, 2025, 3:51 a.m.
Why Is Endometriosis The “Missed Disease”? - IFLScience
Why Is Endometriosis The “Missed Disease”? IFLScience
Published: March 8, 2025, 11:32 a.m.
These 4 reproductive issues have just been linked to heart disease — one affects 25% of women - MSN
These 4 reproductive issues have just been linked to heart disease — one affects 25% of women MSN
Published: March 7, 2025, 7:44 a.m.
Cumbrian brewery to release new beer for International Women's Day - The Mail
Cumbrian brewery to release new beer for International Women's Day The Mail
Published: March 6, 2025, 5 a.m.
Docs slam 'band-aid' fixes for 'period disease' - MD Linx
Docs slam 'band-aid' fixes for 'period disease' MD Linx
Published: March 6, 2025, 3:11 a.m.
ABC-7 at : Local doctor explains the link between endometriosis and heart disease - KVIA
ABC-7 at : Local doctor explains the link between endometriosis and heart disease KVIA
Published: March 6, 2025, 12:36 a.m.
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com
Published: March 5, 2025, 11:04 a.m.
Link copied to clipboard!